Perrigo Co Revenue and Competitors

Allegan, MI USA

Location

$3.2B

Total Funding

Consumer

Industry

Estimated Revenue & Valuation

  • Perrigo Co's estimated annual revenue is currently $5.1B per year.(i)
  • Perrigo Co's estimated revenue per employee is $831,143
  • Perrigo Co's total funding is $3.2B.
  • Perrigo Co's current valuation is $5.3B. (January 2022)

Employee Data

  • Perrigo Co has 6088 Employees.(i)
  • Perrigo Co grew their employee count by 6% last year.

Perrigo Co's People

NameTitleEmail/Phone
1
Global VP, Skincare Marketing at PerrigoReveal Email/Phone
2
VP SalesReveal Email/Phone
3
EVP, General Counsel & Corporate SecretaryReveal Email/Phone
4
SVP & General Manager, Oral CareReveal Email/Phone
5
SVP SalesReveal Email/Phone
6
VP CSCI OperationsReveal Email/Phone
7
EVP & President, Consumer Self-Care AmericasReveal Email/Phone
8
VP, Sustainability & ESGReveal Email/Phone
9
VP R&D, Innovation and Scientific AffairsReveal Email/Phone
10
Head Sales Pharma GermanyReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$8M405%N/AN/A
#2
$6M303%N/AN/A
#3
$1.5M1025%N/AN/A
#4
$31.9M1270%N/AN/A
#5
$2.9M19-21%N/AN/A
#6
$22.8M916%N/AN/A
#7
$0.9M70%N/AN/A
#8
$101.7M3240%N/AN/A
#9
$32.9M1317%N/AN/A
#10
$23.1M92-1%N/AN/A
Add Company

What Is Perrigo Co?

Perrigo Company plc is a leading global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, nutritional products, and active pharmaceutical ingredients (API), as well as receives royalties from Multiple Sclerosis drug Tysabri®. The company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market and an industry leader in pharmaceutical technologies.

keywords:N/A

$3.2B

Total Funding

6088

Number of Employees

$5.1B

Revenue (est)

6%

Employee Growth %

$5.3B

Valuation

N/A

Accelerator

Perrigo Co News

2022-04-20 - Perrigo Co. PLC stock underperforms Monday when compared to competitors

Shares of Perrigo Co. PLC PRGO, -1.64% slipped 1.64% to $35.39 Monday, on what proved to be an all-around poor trading session for the stock...

2022-04-17 - Perrigo Co. PLC stock underperforms Thursday when compared to competitors

Perrigo Co. PLC closed $14.92 below its 52-week high ($50.90), which the company reached on September 30th. The stock demonstrated a mixed...

2022-03-22 - PERRIGO ANNOUNCES CFO RETIREMENT AND ...

Perrigo Company plc (NYSE: PRGO) is a leading provider of Quality, Affordable Self-Care Products and over-the-counter (OTC) health and wellness...

2021-11-10 - Perrigo Reports Third Quarter 2021 Financial Results From Continuing Operations

DUBLIN, Nov. 10, 2021 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO; TASE) ("Perrigo" or the "Company"), a leading provider of Consumer Self-Care Products, today announced financial results for the third quarter of fiscal year 2021 ended October 2, 2021. All comparisons are against the prior y ...

2021-11-02 - Perrigo Announces Quarterly Dividend

DUBLIN, Nov. 2, 2021 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of Quality, Affordable Self-Care Products, today announced that its Board of Directors declared a quarterly dividend of $0.24 per share, payable on December 21, 2021 to shareholders of record o ...